Sources | Names Used |
---|---|
CTRPv2 | Repligen 136 |
PharmacoGx | Repligen 136 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYBL1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | FHL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | ELL2 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | MFSD5 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | GZMK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | ASAP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | RECQL | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | MPP1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | DYNC1I2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
mRNA | TMEM31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |